Literature DB >> 19817620

Global mortality associated with rotavirus disease among children in 2004.

Umesh D Parashar1, Anthony Burton, Claudio Lanata, Cynthia Boschi-Pinto, Kenji Shibuya, Duncan Steele, Maureen Birmingham, Roger I Glass.   

Abstract

BACKGROUND: As new rotavirus vaccines are being introduced in immunization programs, global and national estimates of disease burden, especially rotavirus-associated mortality, are needed to assess the potential health benefits of vaccination and to monitor vaccine impact.
METHODS: We identified 76 studies that were initiated after 1990, lasted at least 1 full year, and examined rotavirus among >100 children hospitalized with diarrhea. The studies were assigned to 5 groups (A-E) with use of World Health Organization classification of countries by child mortality and geography. For each group, the mean rotavirus detection rate was multiplied by diarrhea-related mortality figures from 2004 for countries in that group to yield estimates of rotavirus-associated mortality.
RESULTS: Overall, rotavirus accounted for 527,000 deaths (95% confidence interval, 475,000-580,000 deaths) annually or 29% of all deaths due to diarrhea among children <5 years of age. Twenty-three percent of deaths due to rotavirus disease occurred in India, and 6 countries (India, Nigeria, Congo, Ethiopia, China, and Pakistan) accounted for more than one-half of deaths due to rotavirus disease.
CONCLUSIONS: The high mortality associated with rotavirus disease underscores the need for targeted interventions, such as vaccines. To realize the full life-saving potential of vaccines, it will be vital to ensure that they reach children in countries with high mortality. These baseline figures will allow future assessment of vaccine impact on rotavirus-associated mortality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19817620     DOI: 10.1086/605025

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  163 in total

1.  Mutational analysis of residues involved in nucleotide and divalent cation stabilization in the rotavirus RNA-dependent RNA polymerase catalytic pocket.

Authors:  Kristen M Ogden; Harish N Ramanathan; John T Patton
Journal:  Virology       Date:  2012-06-02       Impact factor: 3.616

Review 2.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

3.  Residues of the rotavirus RNA-dependent RNA polymerase template entry tunnel that mediate RNA recognition and genome replication.

Authors:  Kristen M Ogden; Harish N Ramanathan; John T Patton
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

Review 4.  Rotavirus diversity and evolution in the post-vaccine world.

Authors:  John T Patton
Journal:  Discov Med       Date:  2012-01       Impact factor: 2.970

5.  Prevalence of Rotaviruses Groups A and C in Egyptian Children and Aquatic Environment.

Authors:  Waled Morsy El-Senousy; Ahmed Mohammed El-Sayed Ragab; Eman Mohammed Abd El Hamed Handak
Journal:  Food Environ Virol       Date:  2015-02-11       Impact factor: 2.778

6.  Sociocultural determinants of anticipated vaccine acceptance for acute watery diarrhea in early childhood in Katanga Province, Democratic Republic of Congo.

Authors:  Sonja Merten; Christian Schaetti; Cele Manianga; Bruno Lapika; Raymond Hutubessy; Claire-Lise Chaignat; Mitchell Weiss
Journal:  Am J Trop Med Hyg       Date:  2013-07-22       Impact factor: 2.345

7.  Simian rotaviruses possess divergent gene constellations that originated from interspecies transmission and reassortment.

Authors:  Jelle Matthijnssens; Zenobia F Taraporewala; Hongyan Yang; Shujing Rao; Lijuan Yuan; Dianjun Cao; Yasutaka Hoshino; Peter P C Mertens; Gerry R Carner; Monica McNeal; Karol Sestak; Marc Van Ranst; John T Patton
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

8.  Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.

Authors:  Hiten D Patel; Eric T Roberts; Dagna O Constenla
Journal:  Vaccine       Date:  2013-10-29       Impact factor: 3.641

Review 9.  Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe: serotype distribution and burden of illness.

Authors:  Isla Ogilvie; Hanane Khoury; Antoine C El Khoury; Mireille M Goetghebeur
Journal:  Hum Vaccin       Date:  2011-05-01

10.  The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans.

Authors:  Sasirekha Ramani; Nicolas W Cortes-Penfield; Liya Hu; Sue E Crawford; Rita Czako; David F Smith; Gagandeep Kang; Robert F Ramig; Jacques Le Pendu; B V Venkataram Prasad; Mary K Estes
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.